InforCapital
Companyβ€’United Statesβ€’Updated Apr 4, 2026
Ennovance Capital

Ennovance Capital

Ennovance Capital: Investor, Limited Partner β€’ focus on Private Equity β€’ active in North America, Europe β€’ offices in United States.

Company Profile

Ennovance Capital is a private family office and a privately held investment company headquartered in Philadelphia, Pennsylvania, with a global presence spanning North America, Europe, and Asia. The firm operates as a niche, sector-focused, and operationally-oriented private equity investor, specializing in alternative assets. They are recognized for their stable and permanent capital base and an extensive network, positioning them as ideal partners for entrepreneurs, companies, and fund managers. Ennovance Capital focuses on buyouts, growth capital, and special situations within its target sectors.

The firm was founded in 2009 by Mo Hossain, alongside a team of senior operating executives from leading Fortune 100 chemical companies and seasoned investment professionals. This founding team brought together over 100 years of combined private equity and alternative asset investment experience, complemented by over 150 years of operating experience in the broader chemicals industry. Their deep industry expertise and operational backgrounds are central to their multi-disciplinary investment approach, which emphasizes implementing growth and margin improvement initiatives in collaboration with management teams to create sustainable long-term value.

Ennovance Capital primarily targets lower-middle and middle-market companies with revenues typically ranging from $20 million to $1 billion, EBITDA up to $200+ million, and enterprise values up to $1+ billion. The firm seeks to make equity investments of $200 million to $300+ million. Their investment focus spans the broader chemical industry, including specialty chemicals, allied products, healthcare (as it relates to chemistry), and specialty materials. Notable investments include companies such as Morton Salt, Aemetis, and Culligan ZeroWater.

The team's expertise extends beyond chemical and pharmaceutical industries to include backgrounds in private equity, management and strategy consulting, investment banking, transaction advisory services, and risk management. This diverse skill set enables Ennovance Capital to identify and capitalize on complex opportunities, manage risks effectively, and drive value creation through operational improvements and strategic growth initiatives. They are committed to enhancing portfolio value and are not involved in investment banking, brokerage, or advisory services.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.